Coeptis Therapeutics Holdings (COEP)
NASDAQ:COEP
Total Valuation
Coeptis Therapeutics Holdings has a market cap or net worth of $67.52M. The enterprise value is $32.72M.
Market Cap$67.52M
Enterprise Value$32.72M
Share Statistics
Coeptis Therapeutics Holdings has 6,223,221 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,223,221
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Coeptis Therapeutics Holdings’s return on equity (ROE) is -0.69 and return on invested capital (ROIC) is -71.70%.
Return on Equity (ROE)-0.69
Return on Assets (ROA)-0.60
Return on Invested Capital (ROIC)-71.70%
Return on Capital Employed (ROCE)-0.72
Revenue Per Employee272.61K
Profits Per Employee-2.38M
Employee Count5
Asset Turnover0.07
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Coeptis Therapeutics Holdings is ―. Coeptis Therapeutics Holdings’s PEG ratio is 0.10.
PE Ratio―
PS Ratio44.27
PB Ratio3.50
Price to Fair Value3.50
Price to FCF-7.01
Price to Operating Cash Flow-5.15
PEG Ratio0.10
Income Statement
In the last 12 months, Coeptis Therapeutics Holdings had revenue of 1.36M and earned -11.92M in profits. Earnings per share was -2.81.
Revenue1.36M
Gross Profit-2.83M
Operating Income-13.04M
Pretax Income-12.28M
Net Income-11.92M
EBITDA-11.82M
Earnings Per Share (EPS)-2.81
Cash Flow
In the last 12 months, operating cash flow was -8.60M and capital expenditures -3.00, giving a free cash flow of -8.60M billion.
Operating Cash Flow-8.60M
Free Cash Flow-8.60M
Free Cash Flow per Share-1.38
Dividends & Yields
Coeptis Therapeutics Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.50
52-Week Price Change15.80%
50-Day Moving Average11.96
200-Day Moving Average13.21
Relative Strength Index (RSI)43.94
Average Volume (3m)40.59K
Important Dates
Coeptis Therapeutics Holdings upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Coeptis Therapeutics Holdings as a current ratio of 4.16, with Debt / Equity ratio of 1.56%
Current Ratio4.16
Quick Ratio4.16
Debt to Market Cap<0.01
Net Debt to EBITDA0.46
Interest Coverage Ratio-20.30
Taxes
In the past 12 months, Coeptis Therapeutics Holdings has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Coeptis Therapeutics Holdings EV to EBITDA ratio is -4.65, with an EV/FCF ratio of -6.39.
EV to Sales40.31
EV to EBITDA-4.65
EV to Free Cash Flow-6.39
EV to Operating Cash Flow-6.39
Balance Sheet
Coeptis Therapeutics Holdings has $6.35M in cash and marketable securities with $268.88K in debt, giving a net cash position of $6.08M billion.
Cash & Marketable Securities$6.35M
Total Debt$268.88K
Net Cash$6.08M
Net Cash Per Share$0.98
Tangible Book Value Per Share$4.11
Margins
Gross margin is -207.81%, with operating margin of -956.94%, and net profit margin of -874.29%.
Gross Margin-207.81%
Operating Margin-956.94%
Pretax Margin-900.72%
Net Profit Margin-874.29%
EBITDA Margin-867.24%
EBIT Margin-956.94%
Analyst Forecast
The average price target for Coeptis Therapeutics Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―